INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, OSE IMMUNOTHERAPEUTICS SA FILES APPLICATION FOR "USE OF ANTI-SIRP-ALPHA ANTIBODIES TO TREAT A LIVER DISEASE OR DISORDER"

GENEVA, April 14 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 Ingelheim am Rhein), OSE IMMUNOTHERAPEUTICS SA (22 boulevard Benoni Goullin44200 Nantes CEDEX) filed a patent application (PCT/IB2024/059756) for "USE OF ANTI-SIRP-ALPHA ANTIBODIES TO TREAT A LIVER DISEASE OR DISORDER" on Oct 04, 2024. With publication no. WO/2025/074337, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARNHOLD, Thomas (Boehringer Ingelheim International GmbH, Global PatentsBinger Strasse 17355216 Ingelheim am Rhein), MARZ...